AAAAAA

   
Results: 1-18 |
Results: 18
Improved laboratory confirmation of heparin-induced thrombocytopenia type II - Time course of antibodies and combination of antigen and biologic assays
Authors: Harenberg, J Wang, LC Hoffmann, U Huhle, G Feuring, M
Citation: J. Harenberg et al., Improved laboratory confirmation of heparin-induced thrombocytopenia type II - Time course of antibodies and combination of antigen and biologic assays, AM J CLIN P, 115(3), 2001, pp. 432-438
Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100 (TM)
Authors: Feuring, M Gutfleisch, A Ganschow, A Richter, E Eichler, H Dempfle, CE Tillmann, HC Schultz, A Wehling, M
Citation: M. Feuring et al., Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100 (TM), PLATELETS, 12(4), 2001, pp. 236-240
Acute effects of a single oral dose of carvedilol on cardiac sympathovagalbalance in man
Authors: Haseroth, K Loffler, P Janson, CP Kropff, S Schmidt, BMW Feuring, M Christ, M Wehling, M
Citation: K. Haseroth et al., Acute effects of a single oral dose of carvedilol on cardiac sympathovagalbalance in man, INT J CL PH, 39(7), 2001, pp. 315-321
The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis
Authors: Schmidt, BMW Kusma, M Feuring, M Timmer, WE Neuhauser, M Bethke, T Stuck, BA Hormann, K Wehling, M
Citation: Bmw. Schmidt et al., The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis, J ALLERG CL, 108(4), 2001, pp. 530-536
Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex
Authors: Harenberg, J Wang, LC Hoffmann, U Huhle, G Feuring, M
Citation: J. Harenberg et al., Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex, J LA CL MED, 137(6), 2001, pp. 408-413
Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system
Authors: Schmidt, BMW Georgens, AC Martin, N Tillmann, HC Feuring, M Christ, M Wehling, M
Citation: Bmw. Schmidt et al., Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system, J CLIN END, 86(2), 2001, pp. 761-767
Moxonidine and ramipril in patients with hypertension and obstructive pulmonary disease
Authors: Feuring, M Cassel, W Thun, B Grote, L Wehling, M Penzel, T Peter, JH
Citation: M. Feuring et al., Moxonidine and ramipril in patients with hypertension and obstructive pulmonary disease, CLIN DRUG I, 20(1), 2000, pp. 19-24
Rapid, nongenomic steroid actions: A new age?
Authors: Schmidt, BMW Gerdes, D Feuring, M Falkenstein, E Christ, M Wehling, M
Citation: Bmw. Schmidt et al., Rapid, nongenomic steroid actions: A new age?, FRONT NEURO, 21(1), 2000, pp. 57-94
Specific nongenomic actions of aldosterone
Authors: Falkenstein, E Christ, M Feuring, M Wehling, M
Citation: E. Falkenstein et al., Specific nongenomic actions of aldosterone, KIDNEY INT, 57(4), 2000, pp. 1390-1394
Multiple actions of steroid hormones - A focus on rapid, nongenomic effects
Authors: Falkenstein, E Tillmann, HC Christ, M Feuring, M Wehling, M
Citation: E. Falkenstein et al., Multiple actions of steroid hormones - A focus on rapid, nongenomic effects, PHARM REV, 52(4), 2000, pp. 513-555
Influence of heredity and disease on drug action
Authors: Feuring, M Wehling, M Falkenstein, E
Citation: M. Feuring et al., Influence of heredity and disease on drug action, INTERNIST, 41(4), 2000, pp. 332-337
Determination of serotonin release from platelets by enzyme immunoassay inthe diagnosis of heparin-induced thrombocytopenia
Authors: Harenberg, J Huhle, G Giese, C Wang, LC Feuring, M Song, XH Hoffmann, U
Citation: J. Harenberg et al., Determination of serotonin release from platelets by enzyme immunoassay inthe diagnosis of heparin-induced thrombocytopenia, BR J HAEM, 109(1), 2000, pp. 182-186
Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100)
Authors: Feuring, M Haseroth, K Janson, CP Falkenstein, E Schmidt, BMW Wehling, M
Citation: M. Feuring et al., Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100), INT J CL PH, 37(12), 1999, pp. 584-588
Short term cardiovascular effects of aldosterone in healthy male volunteers
Authors: Schmidt, BMW Montealegre, A Janson, CP Martin, N Stein-Kemmesies, C Scherhag, A Feuring, M Christ, M Wehling, M
Citation: Bmw. Schmidt et al., Short term cardiovascular effects of aldosterone in healthy male volunteers, J CLIN END, 84(10), 1999, pp. 3528-3533
Beta-blockers - Utility in cardiovascular disease
Authors: Feuring, M Schmidt, BMW Christ, M Wehling, M
Citation: M. Feuring et al., Beta-blockers - Utility in cardiovascular disease, INTERNIST, 40(6), 1999, pp. 680-685
Important differences in the metabolism of CSE inhibitors
Authors: Feuring, M Wehling, M
Citation: M. Feuring et M. Wehling, Important differences in the metabolism of CSE inhibitors, INTERNIST, 40(2), 1999, pp. 235-236
Pharmacotherapy for hypertonia in pregnancy
Authors: Feuring, M Melchert, F Wehling, M
Citation: M. Feuring et al., Pharmacotherapy for hypertonia in pregnancy, GYNAKOLOGE, 32(6), 1999, pp. 443-449
Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice
Authors: Haseroth, K Gerdes, D Berger, S Feuring, M Gunther, A Herbst, C Christ, M Wehling, M
Citation: K. Haseroth et al., Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice, BIOC BIOP R, 266(1), 1999, pp. 257-261
Risultati: 1-18 |